Use of family A5 antibody with sequence homology for the treatment of glaucoma

摘要

The present invention relates to pharmaceutical uses of antagonists (eg, antibodies or antigen-binding portions thereof) that specifically bind to FAM19A5 for treating glaucoma of interest.